Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

INTS
Intensity Therapeutics, Inc. Common stock
stock NASDAQ

At Close
May 9, 2025 3:59:58 PM EDT
0.5300USD-6.690%(-0.0380)167,905
0.5300Bid   0.5400Ask   0.0100Spread
Pre-market
May 9, 2025 9:17:30 AM EDT
0.5640USD-0.704%(-0.0040)3,516
After-hours
May 9, 2025 4:43:30 PM EDT
0.5540USD+4.528%(+0.0240)4,302
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Dec 12, 2021
04:56PM EST  The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More   Benzinga
Dec 10, 2021
08:11AM EST  Intensity Therapeutics Reports Early Efficacy Results Using INT230-6 As A Monotherapy Or In Combination With Pembrolizumab In Metastatic Breast Cancer At 2021 San Antonio Breast Cancer Symposium   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC